Privia Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports a financing transaction by Privia Health Group, Inc., a Delaware corporation, with an event date of June 24, 2022. The filing was signed on June 27, 2022. It does not provide operating results for a quarterly or annual reporting period.
Financial Position and Key Metrics
- Term loan repayment: The company voluntarily prepaid approximately $33.1 million, including accrued interest, under its term loan facility.
- Funding source: The repayment was made with cash on hand.
- Prepayment penalty: None was incurred.
- Revolving facility: The $65.0 million revolving loan facility was undrawn as of June 24, 2022 and remained available.
- Debt maturity: Both the prepaid term loan and the revolving facility had scheduled maturity dates of August 27, 2026; the term loan was extinguished before maturity.
The filing does not provide revenue, profit, cash flow, margin, cash balance, or liquidity figures beyond the disclosed debt repayment and undrawn revolving commitment.
Material Changes Versus the Prior Comparable Period
The material change is the elimination of the outstanding term loan debt through voluntary prepayment. The revolving credit facility remains in place and available, subject to its terms.
Guidance, Outlook, Risks, and Unusual Items
- The filing provides no earnings guidance or operating outlook.
- The repayment reduced outstanding indebtedness but used approximately $33.1 million of cash on hand.
- No prepayment penalties were incurred.
- The filing does not disclose the remaining cash balance, any effects on interest expense, or other financial statement impacts.
Investor Verification Items
- Verify the final accounting treatment of the term loan repayment and any related loss, gain, or deferred financing cost write-off.
- Assess the company’s cash balance and liquidity after using approximately $33.1 million of cash.
- Review the terms, covenants, borrowing capacity, and availability of the remaining $65.0 million revolving facility.
- Confirm whether subsequent filings disclose changes in interest expense, leverage, or financing strategy.